Table 7.
The effect of CXCL1 expression level on the survival of patients with colorectal cancer.
| Type of Tumor | Effect on the Survival at High CXCL1 Expression | Number of Patients in the Study | Notes | References |
|---|---|---|---|---|
| Colorectal cancer | Worse prognosis | 62 | OS | [238] |
| Colorectal cancer | Worse prognosis | 91 | RFS, analysis only in stage III patients. In other stages, CXCL1 expression is not related to prognosis | [204] |
| Colorectal cancer | No significant impact on prognosis | 163 | RFS, OS analysis only in stage II patients |
[204] |
| Colorectal cancer | No significant impact on prognosis | 270 | OS, Data from the GEPIA database | [65,206] |
| Colorectal cancer | No significant impact on prognosis | 362 | RFS, OS Data from the GEPIA database |
[65,239] |
| Colorectal cancer | Worse prognosis | 276 | OS, DFS | [233] |
| Colorectal cancer | No significant impact on prognosis | 125 | OS, RFS | [212] |
| Colorectal cancer | Worse prognosis | 45 | OS, only stage IV patients |
[218] |
| Colorectal cancer | No significant impact on prognosis | 70 | OS, Only stage II and III patients |
[218] |
| Colorectal cancer: colon cancer | Better prognosis | 438 | OS, data from TCGA | [52,209,213] |
| Colorectal cancer: colon adenocarcinoma | No significant impact on prognosis | 171 | OS, RFS | [209] |
| Colorectal cancer: rectal adenocarcinoma | Worse prognosis | 304 | OS Data from the TCGA database |
[52,229] |
DFS—disease-free survival; OS—overall survival; RFS—relapse-free survival; red color—worse prognosis; blue color—better prognosis.